Overview
Meera Yogarajah is a Hematologist and an Oncologist practicing medicine in Hamilton, New Jersey.
Dr. Yogarajah is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Myeloproliferative Neoplasms (MPN), Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
She is actively involved in clinical research, co-authoring 17 peer reviewed articles. Dr. Yogarajah is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2575 Klockner Rd, Hamilton, NJ 08690
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rutgers Cancer Institute Of New Jersey
Matthew Matasar is a Hematologist and an Oncologist practicing medicine in New Brunswick, New Jersey. Dr. Matasar is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Matasar is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
Frequently Asked Questions about Dr. Meera Yogarajah
How do I make an appointment with Dr. Meera Yogarajah?
You can book an appointment with Dr. Meera Yogarajah by calling their office at 609-875-4109. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Meera Yogarajah a top-rated expert for Malignant Mixed Mullerian Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meera Yogarajah is classified as an Advanced expert for Malignant Mixed Mullerian Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Meera Yogarajah specialize in?
While Dr. Meera Yogarajah is a Hematology, they have specific expertise in Malignant Mixed Mullerian Tumor, Myeloproliferative Neoplasms (MPN), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Meera Yogarajah participate in research or clinical trials?
Yes. Dr. Meera Yogarajah has published 17 articles and abstracts on conditions like Malignant Mixed Mullerian Tumor. You can view a list of Dr. Meera Yogarajah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Meera Yogarajah accept my insurance?
Dr. Meera Yogarajah accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 609-875-4109 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Malignant Mixed Mullerian TumorDr. Yogarajah isAdvanced. Learn about Malignant Mixed Mullerian Tumor.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Yogarajah isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Mountain SicknessDr. Yogarajah isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloid Leukemia (AML)Dr. Yogarajah isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Yogarajah isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Yogarajah isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Yogarajah isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.